Brandon Temple/LinkedIn
Sep 18, 2026, 15:25
Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research
Brandon Temple, National Legislative Director at Critical Response Group, shared a post on LinkedIn:
“Life is full of surprises.
Never did I think I would be exercising my First Amendment right to petition our government advocating for research into warm autoimmune hemolytic anemia (wAIHA).
When my father in law was diagnosed with this rare blood disease the family felt helpless. I figured I could use my legislative expertise to do my part.
Mike is in compensated remission, but he too decided he needed to be a voice for those who are suffering with this rare disease.”
Stay updated with Hemostasis Today:
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian